The International Stem Cell Corporation (ISCO) (OTCQB:ISCO), a clinical stage biotechnology company based in California, has announced the development of a new 3D bioprinter that produces liver tissue…
WFIRM 3D bioprinted Body on a Chip responds to billion dollar screening deficiency
On average, 90% of new drugs developed by pharmaceutical companies in the U.S. fail to make it to a commercial market due to inadequacy of the current screening process. As a result, the manufacturers…
Harvard-MIT liver chip narrows gap between in vitro and in vivo drug tests
3D bioprinting, microfluidics and hydrogel scaffolding combine in the latest liver tissue research by a team of scientists attributable to seven institutions from across the globe. Centralized at Harv…
Organovo 3D bioprinted liver tissue could make it to the FDA by 2019
Speculation on 3D printed tissue coming to humans sooner than we think is backed by new pre-clinical findings from 3D bioprinting company Organovo (NASDAQ:ONVO). Though it will still be 3 – 5 years be…
3D bioprinting pioneer Organovo share price punished with 15% fall
Organovo (NASDAQ:ONVO) shares fell in response to a financing update yesterday: the company received a 15% hit to its stock price during NASDAQ trading. The California based 3D bioprinting company too…
3D printed liver transplants one step closer
3D printed organ transplants have been in the cards for a while, but deep tissue printing has proved problematic. Now a team of scientists in Korea think they have cracked the code for producing funct…